This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AdCare Health Systems, Inc. Board Of Directors Adds Brent Morrison As Non-Voting Board Observer

ATLANTA, Jan. 17, 2014 /PRNewswire/-- AdCare Health Systems, Inc. (NYSE MKT: ADK) (NYSE MKT: ADK.PRA), a leading long-term care provider, announced today that Brent Morrison, CFA, is serving as a non-voting observer to AdCare's Board of Directors, reflecting AdCare's commitment to effective and shareholder-friendly corporate governance.

Mr. Morrison is currently the Managing Director of Zuma Capital Management LLC, a Registered Investment Advisor, a position he has held since 2012, where he manages the firm's assets by investing in undervalued small-cap companies. Prior to Zuma, Mr. Morrison was the Senior Research Analyst at the Strome Group, a private investment firm, from 2009 to 2012. Mr. Morrison was a Research Analyst at Clocktower Capital, LLC, a global long/short equity hedge fund based in Beverly Hills, Calif., from 2007 to 2009. Prior to that, he was the Vice President of Wilshire Associates, a financial consulting firm, from 1999 to 2007. Mr. Morrison received a MBA from the University of California at Los Angeles, with an emphasis in Finance and International Business, and a B.A. in Finance from the University of Colorado at Denver. Mr. Morrison is a Chartered Financial Analyst.    

"We welcome the expertise that Brent brings to our board as an experienced, shareholder-friendly advocate," commented Boyd Gentry, CEO of AdCare. "Brent has experience as a board observer, having previously served as a board observer.  In addition, he is familiar with AdCare as a result of our prior relationship with the Strome Group, his financial and investment background and his advocacy for creating shareholder value form a powerful combination, and we will benefit from his experience and perspective in the boardroom."

In connection with his designation as board observer, Mr. Morrison has agreed to customary confidentiality obligations with respect to any non-public information concerning AdCare furnished to him in his role as board observer.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,776.91 +93.33 0.53%
S&P 500 2,081.34 +12.58 0.61%
NASDAQ 4,997.4590 +5.5190 0.11%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs